Table: Green Peptide -2016/17 group forecast

BrightPath Biotherapeutics Co

10/02/2017 07:45

Feb 10 (Reuters) - 
              Green Peptide Co., Ltd.      
              CONSOLIDATED EARNINGS ESTIMATES 
  (in billions of yen unless specified)                     
                 Full Year to      Full Year to  
               Mar 31, 2017      Mar 31, 2017    
                  LATEST           PREVIOUS      
                 FORECAST          FORECAST      
  Sales           406 mln                        
  Operating      loss 1.31                       
  Recurring      loss 1.31                       
  Net            loss 1.31                       
  EPS         loss 41.14 yen                     
  
  NOTE - Green Peptide Co., Ltd..     
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
 ((Tokyo Headline News Desk +813 6441 1812))